Deanna Pai writes in New York Magazine about her experiences with ‘chemo brain,’ which is a set of cognitive deficits resulting from chemotherapy. She references a study co-authored by Professor Berman which provides a neurocognitive analysis of breast cancer patients at multiple time points of various treatment conditions. You can read Deanna’s article here, and you can read the research article, “Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis,” here.